The aim of this work was to provide a short overview of existing methods for the determination of free drug concentration and protein-drug binding fraction in plasma. Various methods have been described in terms of principles, evaluation of methods, and applications in recent years, with an emphasis
Consideration of the linear concentration increase of the unbound drug fraction in plasma
β Scribed by Leonid M. Berezhkovskiy
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 169 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
The concentration of drug in plasma may not necessarily be much less than that of the drug binding proteins, as often considered. Thus the unbound drug fraction could be concentration dependent, which should be taken into account in the interpretation of drug pharmacokinetics and modeling. It is shown that the increase of the unbound drug fraction, f u , can be very accurately considered proportional to the drug plasma concentration for a relatively wide range of concentrations. Equations for the calculation of f u in this linear range are obtained, as well the limiting drug concentration when the linear approximation of f u is applicable. The suggested approach greatly simplifies the calculation of f u and can be ready used in pharmacokinetic calculations and PK-PD models, as well as for the prediction of the change of f u due to the variation of protein concentrations in plasma. Naproxen protein binding in human plasma is considered as an illustration of the method.
π SIMILAR VOLUMES
Peritoneal dialysis of a highly protein-bound compound, tolbutamide, was examined in rats to clarify whether the efficacy of the peritoneal dialysis of such compounds increases proportionally as their unbound fractions increase. As expected, it was shown that the tolbutamide concentration of the per
The measurement of the unbound drug fraction in plasma is routinely performed at drug concentrations much less than that of plasma proteins. Commonly, the protein has several binding sites of different affinities. The obtained value of the unbound drug fraction does not yield the affinity of each bi